Treating impaired cognition in schizophrenia: The case for combining cognitive-enhancing drugs with cognitive remediation
- 22 April 2013
- journal article
- review article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 23 (8) , 790-798
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Towards Medication-Enhancement of Cognitive Interventions in Schizophrenia2012
- Combined Cognitive Remediation and Functional Skills Training for Schizophrenia: Effects on Cognition, Functional Competence, and Real-World BehaviorAmerican Journal of Psychiatry, 2012
- Pharmacological Strategies for Enhancing Cognition in Schizophrenia2010
- Preventing the Second Episode: A Systematic Review and Meta-analysis of Psychosocial and Pharmacological Trials in First-Episode psychosisSchizophrenia Bulletin, 2009
- Memantine and constraint‐induced aphasia therapy in chronic poststroke aphasiaAnnals of Neurology, 2009
- Galantamine for the Treatment of Cognitive Impairments in People With SchizophreniaAmerican Journal of Psychiatry, 2008
- Recent Advances in the Development of Novel Pharmacological Agents for the Treatment of Cognitive Impairments in SchizophreniaSchizophrenia Bulletin, 2007
- Amphetamine improves cognitive function in medicated individuals with schizophrenia and in healthy volunteersSchizophrenia Research, 2005
- D-Amphetamine Boosts Language Learning Independent of its Cardiovascular and Motor Arousing EffectsNeuropsychopharmacology, 2004
- Modulation of use‐dependent plasticity by d‐amphetamineAnnals of Neurology, 2001